Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ISB-2001 by Ichnos Glenmark Innovation for Multiple Myeloma (Kahler Disease): Likelihood of Approval
ISB-2001 is under clinical development by Ichnos Glenmark Innovation and currently in Phase I for Multiple Myeloma (Kahler Disease). According...
ISB-2001 by Ichnos Glenmark Innovation for Relapsed Multiple Myeloma: Likelihood of Approval
ISB-2001 is under clinical development by Ichnos Glenmark Innovation and currently in Phase I for Relapsed Multiple Myeloma. According to...
ISB-2001 by Ichnos Glenmark Innovation for Refractory Multiple Myeloma: Likelihood of Approval
ISB-2001 is under clinical development by Ichnos Glenmark Innovation and currently in Phase I for Refractory Multiple Myeloma. According to...